| Name | Title | Contact Details |
|---|---|---|
Mark Bodenrader |
Interim Chief Financial Officer | Profile |
Paul Burgess |
Chief Business Development and Strategic | Profile |
Susan Altschuller |
Chief Financial Officer | Profile |
Jack Homsher |
VP, People and Organizational Capability | Profile |
Richard Gleeson |
Head of Clinical and R&D Technology | Profile |
River Remedy is a medical cannabis company dedicated to serving Mississippi patients with the highest quality plant based medicine.
Ironshore Therapeutics Inc. (formerly known as Highland Therapeutics Inc.) is a pharmaceutical company whose mission is to develop and commercialize first-in-class treatment options to improve the lives of patients and caregivers.
SCOLR Pharma Inc is a Bothell, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant`s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
A global contract research organization (CRO) that offers a full spectrum of resources to meet the drug discovery and drug development needs of the pharmaceutical and biotechnology industries. With facilities in more than 23 countries, MDS Pharma Servi...